Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Fulcrum Therapeutics, Inc. FULC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
64/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.57
+149.3%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Fulcrum Therapeutics, Inc. (FULC), dont 34 achats et 14 ventes. Le total des achats d'initiés s'élève à $29.23M et le total des ventes d'initiés à $10.1M.

Les initiés notables ayant une activité récente comprennent Musso Alan A, Gould Robert J, Sapir Alex. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — FULC

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-02-02 Musso Alan A Chief Financial Officer Attribution de RSU 170,000 $10.72 $1.82M 170,000
2026-02-02 Gould Robert J Director Vente Informative 15,000 $10.72 $160.86K 454,864
2026-02-02 Sapir Alex See Remarks Attribution de RSU 650,000 $10.72 $6.97M 650,000
2026-02-02 Oltmans Curtis Gale Chief Legal Officer Attribution de RSU 170,000 $10.72 $1.82M 170,000
2026-02-02 Tourangeau Greg Principal Accounting Officer Attribution de RSU 57,000 $10.72 $611.04K 57,000
2026-01-02 Gould Robert J Director Vente Informative 15,000 $11.87 $178.09K 469,864
2026-01-02 Gould Robert J Director Vente Informative 15,000 $10.87 $163.09K 469,864
2025-12-15 Oltmans Curtis Gale Chief Legal Officer Vente Informative 3,452 $12.92 $44.6K 10,252
2025-12-08 Ra Capital Management, L.p. 10 Percent Owner Vente Informative 91,722 $14.98 $1.37M 6,053,960
2025-11-19 Gould Robert J Director Vente Informative 15,000 $11.03 $165.5K 484,864
2025-06-26 Geraghty James A Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Gould Robert J Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 King Rachel K. Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Dorton Katina Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Haviland Kate Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Hill Colin Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Ezekowitz Alan Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-06-26 Banks Sonja Director Attribution de RSU 36,000 $7.38 $265.68K 36,000
2025-05-08 Tourangeau Greg Principal Accounting Officer Vente Informative 498 $5.06 $2.52K 14,062
2025-01-24 Musso Alan A Chief Financial Officer Attribution de RSU 285,000 $4.16 $1.19M 285,000
2025-01-24 Sapir Alex See Remarks Attribution de RSU 582,000 $4.16 $2.42M 582,000
2025-01-24 Oltmans Curtis Gale Chief Legal Officer Attribution de RSU 225,000 $4.16 $936K 225,000
2025-01-24 Tourangeau Greg Principal Accounting Officer Attribution de RSU 76,120 $4.16 $316.66K 76,120
2024-11-12 King Rachel K. Officer Inconnu - - - -
2024-11-12 King Rachel K. Director Attribution de RSU 60,000 $3.64 $218.4K 60,000
2024-09-12 Ra Capital Management, L.p. 10 Percent Owner Inconnu 8,500,000 $0.00 $8.5K -
2024-08-21 Ra Capital Management, L.p. 10 Percent Owner Autre (Vente) 8,500,000 $0.00 $8.5K 3,109,704
2024-07-03 Sapir Alex See Remarks Exercice d'Options 150,000 $3.27 $490.5K 193,360
2024-06-17 Geraghty James A Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Gould Robert J Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Dorton Katina Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Haviland Kate Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Hill Colin Director Cession - - - -
2024-06-17 Hill Colin Director Attribution de RSU 60,000 $7.00 $420K 60,000
2024-06-17 Collins James J. Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Ezekowitz Alan Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-06-17 Banks Sonja Director Attribution de RSU 30,000 $7.00 $210K 30,000
2024-05-07 Tourangeau Greg Principal Accounting Officer Vente Informative 236 $7.76 $1.83K 11,571
2024-03-18 Horn Patrick Taylor Chief Medical Officer Cession - - - -
2024-03-18 Horn Patrick Taylor Chief Medical Officer Attribution de RSU 400,000 $10.12 $4.05M 400,000
2024-03-08 Tourangeau Greg Vice President, Finance Vente Informative 4,884 $11.72 $57.22K 11,807
2024-03-04 Sapir Alex See Remarks Achat Informatif 43,360 $11.35 $492.03K 43,360
2024-01-26 Musso Alan A Chief Financial Officer Attribution de RSU 100,000 $6.95 $695K 100,000
2024-01-26 Oltmans Curtis Gale Chief Legal Officer Attribution de RSU 150,000 $6.95 $1.04M 150,000
2024-01-26 Tourangeau Greg Vice President, Finance Attribution de RSU 10,000 $6.95 $69.5K 10,000
2024-01-17 Musso Alan A Chief Financial Officer Attribution de RSU 61,822 $4.01 $247.91K 61,822
2023-08-07 Musso Alan A Chief Financial Officer Cession - - - -
2023-08-07 Musso Alan A Chief Financial Officer Attribution de RSU 432,800 $4.01 $1.74M 432,800
2023-07-01 Sapir Alex See Remarks Cession 2,430,400 $3.27 $7.95M -
2023-06-27 Geraghty James A Director Attribution de RSU 30,000 $3.16 $94.8K 30,000
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message